These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9666226)

  • 21. [Management of patients with essential hypertension. Clinical recommendations and economic data. Guidelines April 2000. Recommendations of the ANAES].
    Agence Nationale d'Accréditation et d'Evaluation en Santé
    J Mal Vasc; 2000 Dec; 25(5):366-376. PubMed ID: 11148400
    [No Abstract]   [Full Text] [Related]  

  • 22. Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors.
    Pérez-Castrillón JL; De Luis D; Martín-Escudero JC; Asensio T; del Amo R; Izaola O
    J Diabetes Complications; 2004; 18(6):317-21. PubMed ID: 15531180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ["New" serum marker for cardiovascular risk].
    Mertz DP
    Dtsch Med Wochenschr; 2004 May; 129(21):1216; author reply 1216. PubMed ID: 15160328
    [No Abstract]   [Full Text] [Related]  

  • 25. Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentrations in women with type 2 diabetes.
    Fukui M; Ose H; Nakayama I; Hosoda H; Asano M; Kadono M; Mogami S; Hasegawa G; Yoshikawa T; Nakamura N
    Diabetes Care; 2007 Jul; 30(7):1886-8. PubMed ID: 17363753
    [No Abstract]   [Full Text] [Related]  

  • 26. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein disorders in diabetes mellitus.
    O'Neill WC
    J Med Assoc Ga; 1989 Nov; 78(11):771-3. PubMed ID: 2691606
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of aging and menopause on lipids and lipoproteins in women.
    Kolovou GD; Bilianou HG
    Angiology; 2008; 59(2 Suppl):54S-7S. PubMed ID: 18515273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased arterial stiffness is associated with reduced plasma levels of beta-carotene in treated hypertensive patients with type 2 diabetes mellitus.
    Chung HK; Kang B; Lee JH; Shim JY; Park S; Lee SH; Park YK; Park E; Chung N; Shin MJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):e9-e11. PubMed ID: 19505810
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
    Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL; ;
    Diabetes Care; 2008 Apr; 31(4):811-22. PubMed ID: 18375431
    [No Abstract]   [Full Text] [Related]  

  • 32. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relation of insulin resistance syndromes to risk of cardiovascular disease.
    Nesto RW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S11-8. PubMed ID: 14668699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P; Korenman S; Davis S
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Good prevention of type 2 diabetes with lipid-lowering statin therapy. Intervention studies support active treatment of risk patients].
    Nilsson PM; Attvall S; Båvenholm P
    Lakartidningen; 2004 Nov; 101(47):3798, 3801-2, 3804. PubMed ID: 15609534
    [No Abstract]   [Full Text] [Related]  

  • 37. Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy.
    Fagan TC; Sowers J
    Arch Intern Med; 1999 May; 159(10):1033-4. PubMed ID: 10335678
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus.
    Syvänne M; Taskinen MR
    Lancet; 1997 Jul; 350 Suppl 1():SI20-3. PubMed ID: 9250279
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipids, thrombosis and cardiovascular disease in diabetes.
    Yudkin JS
    Proc Nutr Soc; 1997 Mar; 56(1B):273-80. PubMed ID: 9168538
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hyperlipemia as cardiovascular risk factor in childhood].
    Sarriá A; Moreno L; Lázaro A; Mur M; Bueno M
    An Esp Pediatr; 1993 Oct; 39 Suppl 55():149-52. PubMed ID: 8291792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.